Evolus, Inc. Comparables
Find the most relevant public market comparables for Evolus, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Evolus, Inc. is a performance beauty company building an aesthetic portfolio of consumer brands in the cash-pay aesthetics market. Its flagship product is Jeuveau®, a proprietary neurotoxin, and it also offers Evolysse™, a line of injectable hyaluronic acid gels.
Business Model
Customer-centric approach delivering breakthrough products in the self-pay aesthetic market. Intentionally moved away from a reimbursement model to provide greater value by partnering with customers differently.
Target Customers
Physicians and other customers who purchase medical products to then sell to consumers or use in aesthetic procedures. Consumers seeking aesthetic treatments.
Specific Focus
Medical aesthetics, specifically injectable neurotoxins and hyaluronic acid fillers for the cash-pay market.
Location
Newport Beach, California
CEO
David Moatazedi
Industry
Life sciences
Sub Sector
Biotechnology: Pharmaceutical Preparations
3yr Revenue Growth
257%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Evolus, Inc. in the Pharmaceuticals sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Evolus, Inc.? Our platform provides detailed analysis of Evolus, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Evolus, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Evolus, Inc. Compset
As a leading player in the Life sciences industry within the Pharmaceuticals sector, Evolus, Inc. operates in the specialized Biotechnology: Pharmaceutical Preparations sub-sector. Understanding how Evolus, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Biotechnology: Pharmaceutical Preparations space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
TG Therapeutics, Inc.
Healthcare • Life sciences
TG Therapeutics, Inc. is a fully integrated, commercial-stage biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. They have received FDA approval for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis.
Vytalize Health
Healthcare • Life sciences
Vytalize Health is a risk-bearing provider enablement platform and leading Accountable Care Organization (ACO) that partners with primary care physicians (PCPs) to deliver value-based care, improving patient outcomes and reducing healthcare costs. They offer an all-in-one solution including value-based incentives, smart technology, and a virtual clinic, enabling independent practices to thrive in value-based care arrangements. The company focuses on Medicare patients and works with over 2,500 PCPs across 36 states.
Talkiatry
Healthcare • Life sciences
Talkiatry is a national mental health practice providing in-network psychiatry and therapy via telehealth. It utilizes technology and a human-centered approach to improve access to high-quality mental healthcare, addressing issues of accessibility and affordability.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Evolus, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free